{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:50:09Z","timestamp":1767988209053,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,7,25]],"date-time":"2016-07-25T00:00:00Z","timestamp":1469404800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s13181-016-0571-7","type":"journal-article","created":{"date-parts":[[2016,7,25]],"date-time":"2016-07-25T13:59:02Z","timestamp":1469455142000},"page":"396-401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation"],"prefix":"10.1007","volume":"12","author":[{"given":"Rachelle","family":"Abouchedid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Dines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R. H.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul I.","family":"Dargan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,25]]},"reference":[{"key":"571_CR1","unstructured":"EMCDDA. European Drug Report (Trends and Developments). 2015. http:\/\/www.emcdda.europa.eu\/edr2015 . Accessed: 15 Nov 2015."},{"key":"571_CR2","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1021\/ja01092a065","volume":"87","author":"R Mechoulam","year":"1965","unstructured":"Mechoulam R, Gaoni Y. A total synthesis of D1-delta-1-tetrahydrocannabinol, the active constituent of hashish. J Am Chem Soc. 1965;87:3273\u20135.","journal-title":"J Am Chem Soc"},{"key":"571_CR3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(01)01112-8","volume":"423","author":"JA Wagner","year":"2001","unstructured":"Wagner JA, Jarai Z, Batkai S, Kunos G. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB1 receptors. Eur J Pharmacol. 2001;423:203\u201310.","journal-title":"Eur J Pharmacol"},{"key":"571_CR4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/35040576","volume":"408","author":"A Calignano","year":"2000","unstructured":"Calignano A, Katona I, Desarnaud F, Giuffrida A, La Rana G, Mackie K, Freund TF, Piomelli D. Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature. 2000;408:96\u2013101.","journal-title":"Nature"},{"key":"571_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0009-3084(00)00196-1","volume":"108","author":"L De Petrocellis","year":"2000","unstructured":"De Petrocellis L, Melck D, Bisogno T, Di Marzo V. Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders. Chem Phys Lipids. 2000;108:191\u2013209.","journal-title":"Chem Phys Lipids"},{"key":"571_CR6","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1063545","volume":"296","author":"RI Wilson","year":"2002","unstructured":"Wilson RI, Nicoll RA. Endocannabinoid signaling in the brain. Science. 2002;296:678\u201382.","journal-title":"Science"},{"key":"571_CR7","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/bjo.2003.032250","volume":"88","author":"I Tomida","year":"2004","unstructured":"Tomida I, Pertwee RG, Azuara-Blanco A. Cannabinoids and glaucoma. Br J Ophthalmol. 2004;88:708\u201313.","journal-title":"Br J Ophthalmol"},{"key":"571_CR8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bjp.0707444","volume":"153","author":"M Maccarrone","year":"2008","unstructured":"Maccarrone M. CB2 receptors in reproduction. Br J Pharmacol. 2008;153:189\u201398.","journal-title":"Br J Pharmacol"},{"key":"571_CR9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1124\/jpet.104.077974","volume":"312","author":"B Le Foll","year":"2005","unstructured":"Le Foll B, Goldberg SR. Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence. JPET. 2005;312:875\u201383.","journal-title":"JPET"},{"key":"571_CR10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.ijo.0802250","volume":"27","author":"D Cota","year":"2003","unstructured":"Cota D, Marsicano G, Lutz B, Vicennati V, Stalla GK, Pasquali R, Pagotto U. Endogenous cannabinoid system as a modulator of food intake. Int J Obes. 2003;27:289\u2013301.","journal-title":"Int J Obes"},{"key":"571_CR11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1517\/14728210902736568","volume":"14","author":"DR Janero","year":"2009","unstructured":"Janero DR, Makriyannis A. Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis. Expert Opin Emerg Drugs. 2009;14:43\u201365.","journal-title":"Expert Opin Emerg Drugs"},{"key":"571_CR12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","volume":"34","author":"WA Devane","year":"1988","unstructured":"Devane WA, Dysarz 3rd FA, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol. 1988;34:605\u201313.","journal-title":"Mol Pharmacol"},{"key":"571_CR13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346:561\u20134.","journal-title":"Nature"},{"key":"571_CR14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/faat.1993.1072","volume":"21","author":"RM Everett","year":"1993","unstructured":"Everett RM, Descotes G, Rollin M, Greener Y, Bradford JC, Benziger DP, Ward SJ. Nephrotoxicity of pravadoline maleate (WIN 48098-6) in dogs: evidence of maleic acid-induced acute tubular necrosis. Fundam Appl Toxicol. 1993;21:59\u201365.","journal-title":"Fundam Appl Toxicol"},{"key":"571_CR15","first-page":"17971","volume":"2011","author":"JL Wiley","year":"2011","unstructured":"Wiley JL, Marusich JA, Huffman JW, Balster RL, Thomas BF. Hijacking of basic research: the case of synthetic cannabinoids. Methods Rep RTI Press. 2011;2011:17971.","journal-title":"Methods Rep RTI Press"},{"key":"571_CR16","unstructured":"EMCDDA. Perspectives on drugs. Synthetic cannabinoids in Europe. 2015. http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_212361_EN_Synthetic%20cannabinoids_updated2015.pdf . Accessed 22 Dec 2015."},{"key":"571_CR17","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.2174\/13816128113199990620","volume":"20","author":"L Karila","year":"2014","unstructured":"Karila L, Roux P, Rolland B, Benyamina A, Reynaud M, Aubin HJ, Lan\u00e7on C. Acute and long-term effects of cannabis use: a review. Curr Pharm Des. 2014;20:4112\u20138.","journal-title":"Curr Pharm Des"},{"key":"571_CR18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jemermed.2010.10.014","volume":"40","author":"AB Schneir","year":"2011","unstructured":"Schneir AB, Cullen J, Ly BT. \u201cSpice\u201d girls: synthetic cannabinoid intoxication. J Emerg Med. 2011;40:296\u20139.","journal-title":"J Emerg Med"},{"key":"571_CR19","first-page":"1","volume":"15","author":"RJ Tait","year":"2015","unstructured":"Tait RJ, Caldicott D, Mountain D, Hill SL, Lenton S. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol (Phila). 2015;15:1\u201313.","journal-title":"Clin Toxicol (Phila)"},{"key":"571_CR20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s13546-015-1104-4","volume":"24","author":"C Lovett","year":"2015","unstructured":"Lovett C, Wood DM, Dargan PI. Pharmacology and toxicology of the synthetic cannabinoid receptor agonists. R\u00e9animation. 2015;24:527\u201341.","journal-title":"R\u00e9animation"},{"key":"571_CR21","unstructured":"EMCDDA\u2013Europol joint publication. EMCDDA\u2013Europol 2014 Annual Report on the implementation of Council Decision 2005\/387\/JHA. 2014. http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_240380_EN_TDAN15001ENN.pdf . Accessed 22 Nov 2015."},{"key":"571_CR22","unstructured":"United Nations Office on Drugs and Crime. Global synthetic drugs assessment amphetamine-type stimulants and new psychoactive substances. 2014. https:\/\/www.unodc.org\/documents\/scientific\/2014_Global_Synthetic_Drugs_Assessment_web.pdf . Accessed 22 Dec 2015."},{"key":"571_CR23","doi-asserted-by":"crossref","unstructured":"De Luca MA, Castelli MP, Loi B, Porcu A, Martorelli M, Miliano C, Kellett K, Davidson C, Stair LJ, Schifano F, Di Chiara G. Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE\/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135. Neuropharmacology. 2015;11.","DOI":"10.1016\/j.neuropharm.2015.11.017"},{"key":"571_CR24","unstructured":"BlueLight. AKB-48-F Experience report. http:\/\/www.bluelight.org\/vb\/threads\/647964-AKB-48-F-Experience-report . Accessed 15 Nov 2015."},{"key":"571_CR25","unstructured":"BlueLight. 627774-Cannabinoid-AKB-48. http:\/\/www.bluelight.org\/vb\/threads\/627774-Cannabinoid-AKB-48 . Accessed 15 Nov 2015."},{"key":"571_CR26","unstructured":"Drugs-Forum. Experiences - 5F-AKB48, BB-22, 5F-PB22, STS-135 Last Gen Noids comparison from experience. https:\/\/drugs-forum.com\/forum\/showthread.php?t=226101 . Accessed 15 Nov 2015."},{"key":"571_CR27","first-page":"53","volume":"26","author":"SMR Gurney","year":"2014","unstructured":"Gurney SMR, Scott KS, Kacinko SL, Presley BC, Logan BK. Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs. Forensic Sci Rev. 2014;26:53\u201378.","journal-title":"Forensic Sci Rev"},{"key":"571_CR28","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1021\/acschemneuro.5b00107","volume":"6","author":"SD Banister","year":"2015","unstructured":"Banister SD, Stuart J, Kevin RC, Edington A, Longworth M, Wilkinson SM, Beinat C, Buchanan AS, Hibbs DE, Glass M, Connor M, McGregor IS, Kassiou M. Effects of Bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. ACS Chem Neurosci. 2015;6:1445\u201358.","journal-title":"ACS Chem Neurosci"},{"key":"571_CR29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/FBP.0000000000000150","volume":"26","author":"MB Gatch","year":"2015","unstructured":"Gatch MB, Forster MJ. \u03949-tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market. Behav Pharmacol. 2015;26:460\u20138.","journal-title":"Behav Pharmacol"},{"key":"571_CR30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1056\/NEJMp1505328","volume":"373","author":"J Trecki","year":"2015","unstructured":"Trecki J, Gerona RR, Schwartz MD. Synthetic cannabinoid\u2013related illnesses and deaths. (perspective). N Engl J Med. 2015;373:2.","journal-title":"N Engl J Med"},{"key":"571_CR31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/0960327114550886","volume":"34","author":"LJ Schep","year":"2015","unstructured":"Schep LJ, Slaughter RJ, Hudson S, Place R, Watts M. Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues. Hum Exp Toxicol. 2015;34:557\u201360.","journal-title":"Hum Exp Toxicol"},{"key":"571_CR32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/15563650.2014.925562","volume":"52","author":"H Gugelmann","year":"2014","unstructured":"Gugelmann H, Gerona R, Li C, Tsutaoka B, Olson KR, Lung D. \u2018Crazy monkey\u2019 poisons man and dog: human and canine seizures due to PB-22, a novel synthetic cannabinoid. Clin Toxicol (Phila). 2014;52:635\u20138.","journal-title":"Clin Toxicol (Phila)"},{"key":"571_CR33","first-page":"138","volume":"2","author":"F Hussain","year":"2014","unstructured":"Hussain F, Al-musawi H, Al-khateeb E, Abu sayf A. Ischemic cerebrovasular accident, uncontrolled seizuresand acute myocardial infarction associated with syn thetic marijuana abuse. Am J Intern Med. 2014;2:138\u201314.","journal-title":"Am J Intern Med"},{"key":"571_CR34","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1360-0443.2012.04078.x","volume":"108","author":"M Hermanns-Clausen","year":"2013","unstructured":"Hermanns-Clausen M, Kneisel S, Szabo B, Auw\u00e4rter V. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction. 2013;108:534\u201344.","journal-title":"Addiction"},{"key":"571_CR35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/jat\/bku048","volume":"38","author":"G Behonick","year":"2014","unstructured":"Behonick G, Shanks KG, Firchau DJ, Mathur G, Lynch CF, Nashelsky M, Jaskierny DJ, Meroueh C. Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22. J Anal Toxicol. 2014;38:559\u201362.","journal-title":"J Anal Toxicol"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-016-0571-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-016-0571-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-016-0571-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-016-0571-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:22:41Z","timestamp":1749010961000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-016-0571-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,25]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["571"],"URL":"https:\/\/doi.org\/10.1007\/s13181-016-0571-7","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,25]]}}}